Factors affecting solubility and penetration of clarithromycin through gastric mucus

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 6, 1998, Pages 569-576

  Grubel P ^a,b   Cave, D R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; ANTIULCER AGENT; BISMUTH SALICYLATE; CLARITHROMYCIN; HYDROTALCITE; MAGALDRATE; STOMACH MUCIN; SUCRALFATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG GRANULE; DRUG PENETRATION; DRUG SOLUBILITY; GEL; NONHUMAN; PH; POWDER; PRIORITY JOURNAL; STOMACH MUCUS; SUSPENSION; SWINE; TABLET; VISCOSITY;

ABSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL ASSAY; CLARITHROMYCIN; GASTRIC MUCIN; GASTRIC MUCOSA; HYDROGEN-ION CONCENTRATION; MUCUS; PERMEABILITY; SOLUBILITY; SWINE; VISCOSITY;

EID: 0031810654     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00329.x     Document Type: Article

References (27)

1. NIH Consensus Conference. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993; 37: 1506-9.
3. McNulty CAM, Dent JC, Ford GA, Wilkinson SP. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22: 729-38.
4. Hessey SJ, Spencer J, Wyatt JI, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134-8.
5. Allen A, Johnson LR, eds. Structure and function of gastrointestinal mucus. In: Physiology of the Gastrointestinal Tract. New York: Raven, 1981: 617-39.
6. Hollander F. The two-component mucus harrier. Arch Intern Med 1954; 93: 107-20.
7. Healey NG. Some experiments on partially purified gastrointestinal mucosubstance. Gastroenterology 1958; 37: 304-12.
8. Bansil R, Stanley HE, LaMont JT. Mucin biophysics. Annu Rev Physiol 1995; 57: 635-57.
9. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double blind trial. Am J Gastroenterol 1993; 88: 1860-4.
10. Guay DR, Craft JC. Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. Pediatr Infect Dis J 1993; 12(Suppl. 3): 106-11.
11. Grübel P, Bhaskar KR, Cave DR, Garik P, Stanley HE, LaMont JT. Interaction of an aluminium-magnesium containing antacid and gastric mucin: possible contribution to the cytoprotective function of antacids. Aliment Pharmacol Ther 1997; 11: 139-15.
12. Gong D, Turner B, Bhaskar KR, LaMont JT. Lipid binding to gastric mucin: protective effect against oxygen radicals. Am J Physiol 1990; 259: G681-6.
13. Smith BF, LaMont JT. Hydrophobic binding properties of bovine gallbladder mucin. J Biol Chem 1984; 259: 12170-7.
14. Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995; 59: 2078-85.
15. Edberg SC, Stamathis G, eds. The measurement of antibiotics in human body fluids: techniques and significance. In: Antibiotics in Laboratory Medicine, 1st edn. Baltimore, MD, USA: Williams & Wilkins. 1986: 381-476.
16. Garrod LP, Lambert HP, O'Grardy F. Antibiotics and Chemotherapy, 5th edn. London: Churchill Livingstone. 1981: 497.
17. MacLean-Fletcher SD, Pollard TD. Viscometric analysis of the gelation of Acanthamoeba extracts and purification of two gelation factors. J Cell Biol 1980; 85: 414-18.
18. Gibaldi M, Feldman S. Mechanisms of surfactant effects on drug absorption. J Pharm Sci 1970; 59: 579-89.
19. Cooreman MP, Krausgrill P, Schumacher B, Hengels MJ. Amoxycillin concentrations in antrum, corpus and Hindus of the stomach after single oral administration. Klin Wochenschr 1989; 67: 12-13.
20. Grübel P, Cave DR. Penetration of amoxicillin, clarithromycin and tetracycline through gastric mucus. Am J Gastroenterol 1996; 91: A650(Abstract).
21. Allen A, Flemström G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993; 75: 823-57.
22. Saggers BA, Lawson D. Some observation on the penetration of antibiotics through mucus in vitro. J Clin Path 1966; 19: 313-17.
23. Bhaskar KR, Gong D, Bansil R, et al. Profound increase in viscosity and aggregation of pig gastric mudn at low pH. Am J Physiol 1991; 261: G1827-32.
24. Cederbrant G, Kahlmeter G, Schalen C, Kamme C. Additive effect of clarithromycin with 14-hydroxyclarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemoth 1994; 34: 1025-9.
25. Mortazavi SA, Smart JD. Factors influencing gel-strengthening at the mucoadhesive-mucus interface. J Pharm Pharmacol 1994; 46: 86-90.
26. Allen A, Foster SNE, Pearson JP. Interaction of a polyacrylate, carbomer, with gastric mudn and pepsin. Br J Pharmacol 1987: 126P.
27. Grübel P, Cave DR. Penetration of amoxicillin and clarithromycin through gastric mucus is affected by the aluminum-magnesium containing antacid Riopan. Gastroenterology 1997; 112: A135(Abstract).